| A-fiber | Myelinated sensory fiber |
| BBB | Blood–brain barrier |
| C-fiber | Unmyelinated nociceptive fiber |
| CFA | Complete Freund’s adjuvant |
| CIP | Congenital insensitivity to pain |
| cLTMR | C-low-threshold mechanoreceptor |
| CNS | Central nervous system |
| COX | Cyclooxygenase |
| DRG | Dorsal root ganglion |
| ECG | Electrocardiogram |
| FDA | U.S. Food and Drug Administration |
| F | Bioavailability |
| HEK293 | Human embryonic kidney 293 cells |
| IEM | Inherited erythromelalgia |
| NaV | Voltage-gated sodium channel |
| NMDA | N-methyl-D-aspartate receptor |
| NSAID | Non-steroidal anti-inflammatory drug |
| PAR-2 | Protease-activated receptor 2 |
| PD | Pharmacodynamics |
| PEPD | Paroxysmal extreme pain disorder |
| PK | Pharmacokinetics |
| PN1 | Alternative name for Nav1.7 |
| SCN | Sodium channel gene family prefix |
| SFN | Small-fiber neuropathy |
| SPID48 | Time-weighted sum of pain intensity difference over 48 h |
| TCAs | Tricyclic antidepressants |
| TRP | Transient receptor potential channels |
| TRPV1 | Transient receptor potential vanilloid 1 |
| TTX | Tetrodotoxin |
| TTX-R | Tetrodotoxin-resistant sodium channels |
| TTX-S | Tetrodotoxin-sensitive sodium channels |
| VAS | Visual analogue scale |
| VGSC | Voltage-gated sodium channel |
| WNT | Wnt signaling pathway |